Bharat Parenterals Schedules Board Meeting for Q2 FY27 Financial Results
Bharat Parenterals Ltd 路 Intimation 路 29 Oct 2026, 5:30 am
Bharat Parenterals Schedules Board Meeting for Q2 FY27 Financial Results Bharat Parenterals Limited has scheduled a Board of Directors meeting on 29th Oct'26 to consider, approve, and take on record the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company securities by designated persons and their immediate relatives has been closed effective 1st Oct'26 and will remain shut until 48 hours post the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Bharat Parenterals Ltd
- Intimation for receipt of Establishment Inspection Report from US FDA by Innoxel Lifesciences Pvt Ltd., a subsidiary company of Bharat Parenterals Limited. 路 05 Nov 2026
- Transcript of Earnings Conference Call of Q2FY27. 路 02 Nov 2026
- Audio Recording of Q2FY27 Earnings Conference Call. 路 30 Oct 2026
- Investor Presentation for the Quarter and Half Year ended on September 30, 2026. 路 29 Oct 2026
- Un-Audited Standalone and Consolidated Financial Results For the Quarter and Half Year Ended On September 30, 2026. 路 29 Oct 2026
- Outcome of the Meeting of the Board of Director of Bharat Parenterals Limited held on October 29, 2026 路 29 Oct 2026
- Approval of Preferential Issue by Shareholders of the Company through EGM Held on October 23, 2026. 路 25 Oct 2026
- Revised Voting Result 路 25 Oct 2026
